DIN 02435136 — SYLVANT 400 MG
SYLVANT is a powder for solution of Siltuximab marketed by RECORDATI RARE DISEASES CANADA INC. The full Siltuximab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02435136
- Brand name
- SYLVANT
- Active ingredient
- Siltuximab
- Strength
- 400 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- RECORDATI RARE DISEASES CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Anti-interleukin-6 (IL-6) monoclonal antibody
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Siltuximab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02435128 | SYLVANT | 100 MG | POWDER FOR SOLUTION | RECORDATI RARE DISEASES CANADA INC | MARKETED |